Literature DB >> 5432592

Significance of positive tests for rheumatoid factor in the prognosis of rheumatoid arthritis. A follow-up study.

A Cats, H M Hazevoet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5432592      PMCID： PMC1031259          DOI： 10.1136/ard.29.3.254

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

1.  COURSE AND PROGNOSIS IN RHEUMATOID ARTHRITIS. A FURTHER REPORT.

Authors:  J J DUTHIE; P E BROWN; L H TRUELOVE; F D BARAGAR; A J LAWRIE
Journal:  Ann Rheum Dis       Date:  1964-05       Impact factor: 19.103

2.  Medical and social aspects of the treatment of rheumatoid arthritis; with special reference to factors affecting prognosis.

Authors:  J J DUTHIE; M THOMPSON; M M WEIR; W B FLETCHER
Journal:  Ann Rheum Dis       Date:  1955-06       Impact factor: 19.103

3.  DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association.

Authors: 
Journal:  Ann Rheum Dis       Date:  1959-03       Impact factor: 19.103

4.  Note on the sheep-cell agglutination test.

Authors:  J H KELLGREN
Journal:  Br Med J       Date:  1957-04-13

5.  Course and prognosis in rheumatoid arthritis.

Authors:  J J DUTHIE; P E BROWN; J D KNOX; M THOMPSON
Journal:  Ann Rheum Dis       Date:  1957-12       Impact factor: 19.103

6.  Characterization of two different agglutinators in the latex fixation test, occurring in normal human sera.

Authors:  F Klein; H A Valkenburg; T L van Zwet; G J Lafeber
Journal:  Immunology       Date:  1966-01       Impact factor: 7.397
  6 in total
  28 in total

1.  Rheumatoid arthritis in Greece. Manifestations in different age groups.

Authors:  A P Andonopoulos; V Galanopoulou; A A Drosos; H M Moutsopoulos
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

2.  The natural history of rheumatoid arthritis: a fifteen year follow-up study. The prognostic significance of features noted in the first year.

Authors:  J J Rasker; J A Cosh
Journal:  Clin Rheumatol       Date:  1984-03       Impact factor: 2.980

3.  Significance of rheumatoid factor isotypes in seronegative rheumatoid arthritis.

Authors:  F Eggelmeijer; H G Otten; H H de Rooy; M R Daha; F C Breedveld
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

4.  A comparison of serum biochemistry in ankylosing spondylitis, seronegative and seropositive rheumatoid arthritis.

Authors:  J S Dixon; H A Bird; V Wright
Journal:  Ann Rheum Dis       Date:  1981-08       Impact factor: 19.103

5.  Enhanced in vitro IgM rheumatoid factor synthesis in seropositive rheumatoid arthritis families.

Authors:  G S Alarcón; B O Barger; R C Go; R T Acton; R E Schrohenloher; W J Koopman
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

6.  Seronegative rheumatoid arthritis, rheumatoid factor cross reactive idiotype expression, and hidden rheumatoid factors.

Authors:  V R Bonagura; J F Wedgwood; N Agostino; L Hatam; L Mendez; I Jaffe; B Pernis
Journal:  Ann Rheum Dis       Date:  1989-06       Impact factor: 19.103

7.  Epidemiological study of HLA and GM in rheumatoid arthritis and related symptoms in an open Dutch population.

Authors:  B M de Jongh; L K van Romunde; H A Valkenburg; G G de Lange; J J van Rood
Journal:  Ann Rheum Dis       Date:  1984-08       Impact factor: 19.103

Review 8.  B lymphocytes and humoral immune responses in rheumatoid arthritis.

Authors:  L S De Clerck
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

9.  Psoriasis and arthritis. II. A cross-sectional comparative study of patients with "psoriatic arthritis" and seronegative and seropositive polyarthritis: clinical aspects.

Authors:  L K van Romunde; A Cats; J Hermans; H A Valkenburg
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

10.  Nephelometry compared with differential antibody titre in routine rheumatoid factor measurements.

Authors:  R K Knight; M H Pritchard
Journal:  Ann Rheum Dis       Date:  1982-08       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.